PortfoliosLab logoPortfoliosLab logo
INSP vs. INMD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

INSP vs. INMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Inspire Medical Systems, Inc. (INSP) and InMode Ltd. (INMD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, INSP achieves a -55.17% return, which is significantly lower than INMD's -10.07% return.


INSP

1D
-2.96%
1M
-5.68%
YTD
-55.17%
6M
-57.78%
1Y
-68.41%
3Y*
-49.18%
5Y*
-26.94%
10Y*

INMD

1D
-1.42%
1M
-3.86%
YTD
-10.07%
6M
-8.45%
1Y
-0.53%
3Y*
-28.39%
5Y*
-22.57%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

INSP vs. INMD - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
INSP
Inspire Medical Systems, Inc.
-55.17%-50.25%-8.87%-19.24%9.48%22.31%153.46%12.00%
INMD
InMode Ltd.
-10.07%-12.04%-24.91%-37.70%-49.42%197.30%21.12%187.71%

Correlation

The correlation between INSP and INMD is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.28

Correlation (3Y)
Calculated over the trailing 3-year period

0.30

Correlation (5Y)
Calculated over the trailing 5-year period

0.42

Correlation (All Time)
Calculated using the full available price history since Aug 8, 2019

0.39

The correlation between INSP and INMD shifts across timeframes, from 0.28 (1 year) to 0.42 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

INSP:

$1.19B

INMD:

$844.67M

EPS

INSP:

$4.48

INMD:

$1.36

PE Ratio

INSP:

9.23

INMD:

9.68

PS Ratio

INSP:

1.32

INMD:

2.25

PB Ratio

INSP:

1.50

INMD:

1.28

Total Revenue (TTM)

INSP:

$915.25M

INMD:

$374.64M

Gross Profit (TTM)

INSP:

$785.06M

INMD:

$291.61M

EBITDA (TTM)

INSP:

$67.14M

INMD:

$98.61M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

INSP vs. INMD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INSP
INSP Risk / Return Rank: 66
Overall Rank
INSP Sharpe Ratio Rank: 77
Sharpe Ratio Rank
INSP Sortino Ratio Rank: 66
Sortino Ratio Rank
INSP Omega Ratio Rank: 55
Omega Ratio Rank
INSP Calmar Ratio Rank: 44
Calmar Ratio Rank
INSP Martin Ratio Rank: 77
Martin Ratio Rank

INMD
INMD Risk / Return Rank: 3939
Overall Rank
INMD Sharpe Ratio Rank: 4242
Sharpe Ratio Rank
INMD Sortino Ratio Rank: 3737
Sortino Ratio Rank
INMD Omega Ratio Rank: 3636
Omega Ratio Rank
INMD Calmar Ratio Rank: 4141
Calmar Ratio Rank
INMD Martin Ratio Rank: 4141
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

INSP vs. INMD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Inspire Medical Systems, Inc. (INSP) and InMode Ltd. (INMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


INSPINMDDifference
Sharpe ratioReturn per unit of total volatility

-0.90

Sortino ratioReturn per unit of downside risk

-1.73

Omega ratioGain probability vs. loss probability

0.79

1.03

-0.24

Calmar ratioReturn relative to maximum drawdown

-0.95

-0.02

-0.93

Martin ratioReturn relative to average drawdown

-1.45

-0.05

-1.40

INSP vs. INMD - Sharpe Ratio Comparison

The current INSP Sharpe Ratio is -0.92, which is lower than the INMD Sharpe Ratio of -0.02. The chart below compares the historical Sharpe Ratios of INSP and INMD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

INSP vs. INMD - Drawdown Comparison

The maximum INSP drawdown since its inception was -87.72%, roughly equal to the maximum INMD drawdown of -86.96%. Use the drawdown chart below to compare losses from any high point for INSP and INMD.


Loading charts...

Drawdown Indicators


INSPINMDDifference

Max Drawdown

Largest peak-to-trough decline

-87.72%

-86.96%

-0.76%

Max Drawdown (1Y)

Largest decline over 1 year

-72.19%

-23.23%

-48.96%

Max Drawdown (3Y)

Largest decline over 3 years

-87.72%

-72.28%

-15.44%

Max Drawdown (5Y)

Largest decline over 5 years

-87.72%

-86.96%

-0.76%

Current Drawdown

Current decline from peak

-87.32%

-86.50%

-0.82%

Average Drawdown

Average peak-to-trough decline

-27.91%

-56.14%

+28.23%

Ulcer Index

Depth and duration of drawdowns from previous peaks

47.31%

11.70%

+35.61%

Volatility

INSP vs. INMD - Volatility Comparison

Inspire Medical Systems, Inc. (INSP) has a higher volatility of 10.74% compared to InMode Ltd. (INMD) at 4.28%. This indicates that INSP's price experiences larger fluctuations and is considered to be riskier than INMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


INSPINMDDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.74%

4.28%

+6.46%

Volatility (6M)

Calculated over the trailing 6-month period

46.88%

25.32%

+21.56%

Volatility (1Y)

Calculated over the trailing 1-year period

74.93%

32.67%

+42.26%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

60.32%

52.15%

+8.17%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

60.48%

60.74%

-0.26%

Dividends

INSP vs. INMD - Dividend Comparison

Neither INSP nor INMD has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

INSP vs. INMD - Financials Comparison

This section allows you to compare key financial metrics between Inspire Medical Systems, Inc. and InMode Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


50.00M100.00M150.00M200.00M250.00M20222023202420252026
204.58M
82.02M
(INSP) Total Revenue
(INMD) Total Revenue
Values in USD except per share items

INSP vs. INMD - Profitability Comparison

The chart below illustrates the profitability comparison between Inspire Medical Systems, Inc. and InMode Ltd. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

76.0%78.0%80.0%82.0%84.0%86.0%20222023202420252026
86.5%
75.1%
Portfolio components
INSP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Inspire Medical Systems, Inc. reported a gross profit of 176.91M and revenue of 204.58M. Therefore, the gross margin over that period was 86.5%.

INMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, InMode Ltd. reported a gross profit of 61.55M and revenue of 82.02M. Therefore, the gross margin over that period was 75.1%.

INSP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Inspire Medical Systems, Inc. reported an operating income of -1.12M and revenue of 204.58M, resulting in an operating margin of -0.6%.

INMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, InMode Ltd. reported an operating income of 10.06M and revenue of 82.02M, resulting in an operating margin of 12.3%.

INSP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Inspire Medical Systems, Inc. reported a net income of -11.29M and revenue of 204.58M, resulting in a net margin of -5.5%.

INMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, InMode Ltd. reported a net income of 11.56M and revenue of 82.02M, resulting in a net margin of 14.1%.


Frequently Asked Questions


INSP and INMD have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

INSP has higher volatility (10.74%) compared to INMD (4.28%). In terms of maximum drawdown, INSP dropped -87.72% vs INMD's -86.96%.

INMD currently has the higher Sharpe Ratio (-0.02 vs -0.92), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for INSP and INMD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer